p300/CBP keeps chromatin silent

被引：0
|
作者：
Katharine H. Wrighton
机构：
[1] Nature Structural & Molecular Biology,
来源：
Nature Structural & Molecular Biology | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1039 / 1039
相关论文
共 50 条
  • [41] p300 and CBP as transcriptional regulators and targets of oncogenic events
    Eckner, R
    BIOLOGICAL CHEMISTRY, 1996, 377 (11) : 685 - 688
  • [42] Interaction between acetylated MyoD and the bromodomain of CBP and/or p300
    Polesskaya, A
    Naguibneva, I
    Duquet, A
    Bengal, E
    Robin, P
    Harel-Bellan, A
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) : 5312 - 5320
  • [43] Discovery of a Potent and Selective Covalent p300/CBP Inhibitor
    Mastracchio, Anthony
    Lai, Chunqiu
    Digiammarino, Enrico
    Ready, Damien B.
    Lasko, Loren M.
    Bromberg, Kenneth D.
    McClellan, William J.
    Montgomery, Debra
    Manaves, Vlasios
    Shaw, Bailin
    Algire, Mikkel
    Patterson, Melanie J.
    Sun, Chaohong C.
    Rosenberg, Saul
    Lai, Albert
    Michaelides, Michael R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (05): : 726 - 731
  • [44] Role of Cbp and P300 in Smooth Muscle Cell Plasticity
    Chakraborty, Raja
    Ostriker, Allison
    Hwa, John
    Martin, Kathleen
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [45] Epigenetic Factor CBP/p300 in Pulmonary Arterial Hypertension
    Bourgeois, Alice
    Habbout, Karima
    Robert, William
    Orcholski, Mark
    Breuils-Bonnet, Sandra
    Paulin, Roxane
    Provencher, Steeve
    Bonnet, Sebastien
    Boucherat, Olivier
    CIRCULATION, 2019, 140
  • [46] Designing p300/CBP histone acetyltransferase inhibitors for cancer
    Cole, Philip A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [47] The coactivators CBP and p300 in androgen independent prostate cancer
    Debes, JD
    Culig, Z
    Tindall, DJ
    HORMONAL CARCINOGENESIS IV, 2005, : 494 - 500
  • [48] Current development of CBP/p300 inhibitors in the last decade
    He, Zhang-Xu
    Wei, Bing-Fei
    Zhang, Xin
    Gong, Yun-Peng
    Ma, Li-Ying
    Zhao, Wen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
  • [49] Targeting cancer with selective cbp/p300 bromodomain inhibitors
    Jaleel, Mahaboobi
    Senaiar, Ramesh S.
    Abbineni, Chandrasekhar
    Renukappa, Girish A.
    Mukherjee, Subhendu
    Marappan, Sivapriya
    Samiulla, D. S.
    Aravind, A. B.
    Kumar, Naveen R.
    Reddy, Venkata Siva N.
    Babu, Asha
    Srinivas, Akhila P.
    Yadlapalli, Prasad
    Tgore, Suraj
    Raghavendra, N. R.
    Naik, Chandranath D.
    Giri, Sanjeev
    Antony, Thomas
    Nellore, Kavitha
    Chelur, Shekar
    Daginakatte, Girish
    Ravanti, laura
    Myllymaki, Mikko
    Wohlfahrt, Gerd
    Mattila, Elina
    Karlsson, Stefan
    Bjorkman, Mari
    Riikonen, Reetta
    Ikonen, Tarja
    Leimu, Laura
    Malmstrom, Chira
    Korjamo, Timo
    Moilanen, Anu
    Ramachandra, Murali
    Samajdar, Susanta
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Epigenetic mechanisms to propagate histone acetylation by p300/CBP
    Masaki Kikuchi
    Satoshi Morita
    Masatoshi Wakamori
    Shin Sato
    Tomomi Uchikubo-Kamo
    Takehiro Suzuki
    Naoshi Dohmae
    Mikako Shirouzu
    Takashi Umehara
    Nature Communications, 14
12345